GLOBAL-SAVINGS-GROUP
7.12.2022 16:40:39 CET | Business Wire | Press release
Global Savings Group (GSG) and Pepper.com (Pepper) have signed a deal to join forces, combining the world’s largest shopping community with Europe’s leading shopping recommendation and rewards company. The transaction marks the biggest deal in the industry in 2022 and creates a European Champion with a global footprint. Together, GSG and Pepper will form a multinational tech company empowering shoppers in more than 20 markets to make more confident shopping decisions. GSG and Pepper will jointly operate the world’s largest shopping community, recommendation and rewards platform connecting brands and retailers with consumers across more than 2bn purchase journeys annually.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221130006042/en/
Fabian Spielberger (CEO and Founder Pepper.com) and Gerhard Trautmann (CEO and Co-founder Global Savings Group) are about to join forces. (Photo: Business Wire)
“We are incredibly excited about this industry-disrupting deal that reinforces our leading position in Europe. Together with Pepper, we will significantly enhance our ability to empower consumers and play an even more meaningful role in their daily lives which will open a wide field of development opportunities to shape the future of our industry together. Jointly, we will create a unique, impactful and even more comprehensive portfolio of shopping solutions with huge benefits for consumers, brands, retailers and publishers alike at a scale that's just not possible anywhere else. Together, we will increase our transformative impact and boost GSG’s growth”, states Dr. Gerhard Trautmann, CEO of GSG.
“Our primary focus has always been to offer the best and broadest of money saving solutions to our communities. Our collaboration with GSG will speed up this process significantly as it empowers us to branch out more. Combined, we have more than 20 years of experience in helping people to make smarter decisions and together we will provide even better and more rewarding shopping experiences. Our loyal customers and many more to come will benefit from our combined contents and technologies”, comments Fabian Spielberger, CEO of Pepper.
GSG and Pepper are both market leaders in their fields and have expanded their solutions and services through strategic acquisitions and organic growth. After the 2018 takeover of the UK loyalty specialist Pouch, GSG acquired iGraal and Shoop, the leading French and German cashback brands in 2020 and 2021 respectively, and just recently the US-based consumer brand and domain Coupons.com. Pepper has always shared GSG’s ambition to consolidate the fast-growing market in the sector and has expanded internationally since 2014. Today, Pepper operates market-leading social commerce platforms such as Dealabs, hotukdeals and mydealz. Together, GSG and Pepper will continue to develop and leverage technology to build the leading platform of shopping solutions and services to constantly drive future growth in current and new markets and verticals.
About GSG
GSG is Europe’s largest shopping rewards company with an international footprint across more than 20 markets. The company’s goal is to empower consumers to get more out of life by providing them access to best savings, cashback, deals, product inspiration, reviews and other digital shopping services. Founded in 2012 and headquartered in Munich, GSG employs more than 700 employees in 12 offices across the globe.
About Pepper
Pepper.com is the world's largest shopping community. From its headquarter in Berlin and offices in Guadalajara, London, Lyon and Winnipeg, the Pepper Media Holding operates market-leading social commerce platforms such as Dealabs, hotukdeals and mydealz.de which are used by 25 million consumers per month and influences 12,000 purchase decisions per minute. The company was founded in 2014 by Fabian Spielberger and Paul Nikkel.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221130006042/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 202619.2.2026 08:50:00 CET | Press release
Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February 18-21, 2026), in Los Angeles. The poster showcases new preclinical data and early clinical insights from the company's lead candidate, STC-1010, supporting it as a promising therapeutic option for MSS, immune-cold colorectal cancer (CRC)—a major unmet clinical need. In a syngeneic CT26 model, murine STC-1010 significantly inhibits tumor growth and extends survival by 40%. New mechanistic datas reveal expansion of CD4⁺ and CD8⁺ T cells in draining lymph nodes alongside a significant humoral response compared to control, demonstrating coordinated cellular and humoral immune activation in vivo. Other findings show that dendritic cells efficiently capture STC-1010, leading to their activation as demonstrated by transcripto
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer19.2.2026 08:30:00 CET | Press release
Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM1 If approved, Daiichi Sankyo and AstraZeneca’s ENHERTU has the potential to become a new standard of care in this early breast cancer setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committ
NHOA Energy Advances Delivery of the 51 MWh Broni Battery for Neoen in Italy19.2.2026 08:00:00 CET | Press release
The project confirms NHOA Energy’s long-term commitment to the Italian market NHOA Energy, global provider of utility-scale energy storage systems, is advancing the construction of the Broni Battery, a 10 MW/51 MWh project located in Broni (Pavia), Italy, executed for Neoen, one of the world’s leading independent producers of renewable energy. Civil works at the site are currently underway and advancing on schedule, with commissioning activities planned to start in late spring 2026. Once operational, the Broni Battery will provide essential flexibility services to the Italian electricity system, supporting grid stability and reliability as renewable energy penetration continues to increase. The project represents Neoen’s first battery storage asset in Italy and marks a strategic step in the company’s expansion, as it continues to grow its battery storage portfolio in key markets worldwide to support power system flexibility. The Broni Battery further strengthens NHOA Energy’s long-term
Compass Pathways Announces Pricing of $150 Million Public Offering19.2.2026 02:18:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs at a public offering price of $7.9999 per pre-funded warrant. In addition, Compass Pathways has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 ADSs at the public offering price, less the underwriting discounts and commissions. All of the securities are to be sold by Compass Pathways. The offering is expected to close on or about February 20, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other est
Andersen Consulting udvider sine kompetencer inden for ledelsesrekruttering med Lansdowne Executive Search18.2.2026 17:08:00 CET | Pressemeddelelse
Andersen Consulting styrker sin humancapital-praksis gennem en samarbejdsaftale med Lansdowne Executive Search, der er en Dublin-baseret virksomhed med speciale i lederrekruttering, midlertidige ledelser og bestyrelsesudnævnelser. Lansdowne Executive Search er en irisk-ejet virksomhed, der blev grundlagt i 2015, og som tilbyder C-level-ledelsesekruttering, deltidsledere og bestyrelsesplaceringer. Som en partnerdrevet boutique-virksomhed er Lansdowne kendt for, at seniorledelsen er tæt involveret i alle kundeprojekter. Virksomheden hjælper kunder med at navigere i komplekse ledelsesovergange og vækststrategier på tværs af en bred vifte af sektorer, herunder finans, byggeindustrien, nonprofit, landbrug, videregående uddannelse, den offentlige sektor samt teknologi, medier og telekommunikation. "God ledelse er afhænger af situationen, og det kræver forståelse af langt mere end blot et CV," sagde Tom Keane, der er partner hos Lansdowne Executive Search. "Samarbejdet med Andersen Consulting
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom